Ensysce Biosciences, Inc. (ENSC)
Ensysce Biosciences, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Ensysce Biosciences, Inc. (ENSC) is a Biotechnology company based in US with a market capitalization of $2.6M. Revenue declined 2.8% year-over-year and free cash flow was negative at -$7.8T. This page tracks ENSC's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 7 employees · IPO Mar 14, 2018
Valuation
Valuation & price
$0.28as of May 17, 2026· -89.1% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
0.00
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$2.6M
Market cap
-2.8%
Revenue growth (YoY)
0.0%
Gross margin
-$7.8T
Free cash flow (USD)
-$4T
Net debt
Net cash position
46.4%
Share dilution
2/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2025
Free cash flow by year
2017 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: May 15, 2026 (EPS $-0.52)
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- 8-K eventJul 15, 2026Filing
COO Resignation
- FinancingJun 4, 2026Filing
Securities Registration
- 8-K eventMay 22, 2026Filing
Delisting Notice
- 8-K eventMay 15, 2026Filing
Q1 2026 Financial Results
- Quarterly reportMay 15, 2026Filing
10-Q Filed
- FinancingApr 9, 2026Filing
Securities Registration
- 8-K eventApr 8, 2026Filing
Common Stock Purchase Warrant
- 8-K eventApr 3, 2026Filing
Director Resignation
Questions
Frequently asked questions
What is Ensysce Biosciences, Inc.'s market cap?
Ensysce Biosciences, Inc. (ENSC) has a market capitalization of $2.6M.
What is ENSC's P/E ratio?
A meaningful P/E ratio is not available for ENSC — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is ENSC's price-to-book (P/B) ratio?
ENSC trades at 0.00 times book value per share.
When did Ensysce Biosciences, Inc. last report earnings?
ENSC last reported earnings on May 15, 2026; the next date is not yet scheduled.
Are insiders buying ENSC stock?
SEC Form 4 filings show no open-market insider buys at Ensysce Biosciences, Inc. in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.